NeuroCode AG (founded in 2003) acts as a Contract Research Organisation offering preclinical drug discovery, certified clinical trials and advertisement research by combining Neurocode Tracking (fast dynamic quantitative EEG analysis) with eye tracking. NeuroCode AG has developed the fastest quantitative analysis of electric brain activity (single epoch length of 364 ms corresponding to about 3 pictures/second) to be used concomitantly with eye tracking. Surrogate parameters like visual perception, memory, focused attention, enjoyment, tension, mental activation are followed gaze by gaze quantitatively. Interpretation of spectral signatures of electric brain activity (Enkephaloglyphs) is based on more than 30 years experience of Prof. Dr. Wilfried Dimpfel (Justus-Liebig-University Giessen, Germany).
35578, Wetzlar, Germany